Publications Citing Use of Elabscience Products

Literature Quick Search

FILTERS Clear All

Year

2025 (10708)
2024 (11357)
2023 (7886)
2022 (5166)
2021 (3396)
2020 (2205)
2019 (1498)
2018 (926)
2017 (494)
2016 (296)
2015 (118)
2014 (48)
2013 (6)
2012 (1)

Research Area

immunology (14520)
bioengineering (7739)
neuroscience (6252)
oncology (5922)
food science & nutrition study (3859)
cardiovascular disease (3608)
digestive system disorder (3327)
diabetes & complications (3020)
infectious disease (2490)
environmental science & ecological conservation (2360)
kidney disease (1705)
dermatological condition (1096)
others (394)
orthopedics (252)
obesity study (129)
respiratory system disorder (76)
oxidative stress (52)
dentistry (41)
reproductive medicine (37)
endocrinology (36)
sleep research (9)

Country

Afghanistan (1)
Albania (1)
Algeria (2)
Angola (1)
Argentina (11)
Armenia (7)
Australia (332)
Austria (68)
Azerbaijan (5)
Bahrain (6)
Bangladesh (26)
Barbados (1)
Belarus (24)
Belgium (74)
Benin (1)
Bosnia & herzegovina (9)
Botswana (6)
Brazil (281)
Bulgaria (82)
Burkina faso (6)
Cambodia (1)
Cameroon (29)
Canada (324)
Cayman islands (1)
Chile (18)
China (33940)
Chinese taiwan (5)
Colombia (21)
Croatia (22)
Cuba (3)
Cyprus (19)
Czech (2)
Czechia (42)
Denmark (53)
Ecuador (1)
Egypt (1335)
Estonia (3)
Ethiopia (6)
Fiji (3)
Finland (66)
France (225)
Gabon (2)
Gambia (2)
Georgia (2)
Germany (487)
Ghana (25)
Greece (88)
Grenada (1)
Guatemala (1)
Guinea (1)
Guyana (1)
Honduras (1)
Hungary (29)
Iceland (1)
India (1402)
Indonesia (243)
Iran (331)
Iraq (200)
Ireland (40)
Israel (52)
Italy (799)
Japan (402)
Jordan (72)
Kazakhstan (7)
Kenya (7)
Korea (331)
Kuwait (13)
Kyrgyzstan (4)
Latvia (1)
Lebanon (22)
Libya (4)
Lithuania (25)
Luxembourg (1)
Macao (16)
Madagascar (2)
Malaysia (475)
Mexico (44)
Moldova (3)
Mongolia (6)
Montenegro (2)
Morocco (16)
Myanmar (1)
Namibia (11)
Nepal (4)
Netherlands (120)
New zealand (39)
Niger (1)
Nigeria (552)
North macedonia (6)
Norway (25)
Oman (18)
Pakistan (286)
Palestine (1)
Panama (1)
Paraguay (1)
Peru (3)
Philippines (4)
Poland (271)
Portugal (53)
Qatar (17)
Romania (187)
Russia (214)
Russian federation (1)
Rwanda (15)
Saint kitts & nevis (1)
Saudi arabia (680)
Senegal (1)
Serbia (116)
Singapore (123)
Slovakia (13)
Slovenia (12)
Somalia (1)
South africa (321)
South korea (157)
Spain (376)
Sri lanka (12)
Sudan (19)
Sweden (119)
Switzerland (108)
Syria (6)
Taiwan (278)
Tanzania (5)
Thailand (208)
Tonga (1)
Tunisia (25)
Turkey (1585)
Uae (128)
Uganda (20)
Uk (480)
Ukraine (65)
United arab emirates (2)
United kingdom (2)
Uruguay (4)
Usa (1877)
Uzbekistan (20)
Venezuela (4)
Vietnam (21)
Yemen (13)
Zambia (2)
Zimbabwe (4)

Elabscience^® is always dedicated to help scientists and researchers in life science field by providing elaborate, reliable and strictly quality-controlled products manufactured in house, including ELISA Kits, CLIA Kits, Antibodies, FCM antbodies, Protein, Metabolism Assay Kits etc. Our products have helped over 29,532 papers be published in SCI journals, covering many top journals like Nature Medicine, Nature, Cell, Immunity, Molecular Cancer, etc.

Customers speak highly of us: Products with high reproducibility and precise assay result ! Professional and considerate technical support! Excellent package and fast delivery!

Filter

Targeted Nanosensitizer-Augmented Sono-Immunotherapy with STING Agonist to Remodel the Immune Microenvironment in Hepatocellular Carcinoma

IF: 9.400

Journal: Acta Biomaterialia(2025)
DOI: 10.1016/j.actbio.2025.05.029
Products: H22 Cells Line, DC2.4 Cells Line, Hep G2 Cells Line
Product Category: Cell Line

Brain-targeted polymersomes mediating RNAi of STAT3 sensitize glioblastoma to temozolomide and immunotherapy

IF: 9.400

Journal: JOURNAL OF COLLOID AND INTERFACE SCIENCE(2025)
DOI: 10.1016/j.jcis.2025.137751
Products: bEnd.3 [BEND3] Cell Complete Medium
Product Category: Cell Culture Medium

The role of positive feedback loop between LINC00862 and RBM47 in hepatocellular carcinoma suppression

IF: 9.400

Journal: Genes & Diseases(2025)
DOI: 10.1016/j.gendis.2025.101763
Products: Hep 3B2.1-7 Cells Line, Hep G2 Cells Line, SK-Hep-1 Cells Line, HuH-7 Cells Line
Product Category: Cell Line

Druggable target ATAD2 enhances the malignant progression and cooperates with E2F1 to up-regulate PDK1 expression in glioma

IF: 9.400